Profund Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$277K Sell
2,435
-37
-1% -$4.21K 0.01% 727
2025
Q1
$260K Buy
2,472
+49
+2% +$5.15K 0.01% 755
2024
Q4
$260K Sell
2,423
-494
-17% -$52.9K 0.01% 839
2024
Q3
$292K Sell
2,917
-238
-8% -$23.8K 0.01% 816
2024
Q2
$266K Buy
+3,155
New +$266K 0.01% 796
2023
Q2
Sell
-3,010
Closed -$221K 1104
2023
Q1
$221K Buy
+3,010
New +$221K 0.01% 940
2022
Q1
Sell
-2,377
Closed -$229K 1382
2021
Q4
$229K Sell
2,377
-268
-10% -$25.8K 0.01% 1187
2021
Q3
$230K Buy
+2,645
New +$230K 0.01% 1159
2021
Q2
Sell
-2,132
Closed -$203K 1429
2021
Q1
$203K Buy
+2,132
New +$203K 0.01% 1259
2019
Q3
Sell
-11,195
Closed -$797K 1306
2019
Q2
$797K Sell
11,195
-1,010
-8% -$71.9K 0.04% 438
2019
Q1
$957K Buy
12,205
+1,000
+9% +$78.4K 0.05% 357
2018
Q4
$949K Sell
11,205
-6,141
-35% -$520K 0.06% 283
2018
Q3
$2.97M Sell
17,346
-50
-0.3% -$8.56K 0.11% 157
2018
Q2
$2.25M Buy
17,396
+268
+2% +$34.6K 0.09% 186
2018
Q1
$1.77M Buy
17,128
+1,074
+7% +$111K 0.07% 242
2017
Q4
$1.37M Sell
16,054
-1,524
-9% -$130K 0.05% 332
2017
Q3
$1.49M Buy
17,578
+1,085
+7% +$92.2K 0.06% 290
2017
Q2
$1.25M Sell
16,493
-18
-0.1% -$1.36K 0.06% 312
2017
Q1
$1.09M Sell
16,511
-1,515
-8% -$100K 0.05% 393
2016
Q4
$1.14M Sell
18,026
-1,085
-6% -$68.8K 0.05% 360
2016
Q3
$1.22M Buy
19,111
+15,993
+513% +$1.02M 0.06% 310
2016
Q2
$232K Sell
3,118
-168
-5% -$12.5K 0.01% 1277
2016
Q1
$220K Sell
3,286
-1,379
-30% -$92.3K 0.01% 1284
2015
Q4
$316K Buy
+4,665
New +$316K 0.02% 911
2015
Q3
Sell
-5,619
Closed -$354K 1302
2015
Q2
$354K Sell
5,619
-3,294
-37% -$208K 0.01% 1007
2015
Q1
$429K Buy
+8,913
New +$429K 0.02% 999
2014
Q3
Sell
-8,470
Closed -$329K 1390
2014
Q2
$329K Buy
8,470
+2,736
+48% +$106K 0.01% 1159
2014
Q1
$241K Sell
5,734
-4,039
-41% -$170K 0.01% 1339
2013
Q4
$321K Buy
+9,773
New +$321K 0.01% 1352